![Resumen: Teva ha pesentado nuevos datos en el congreso de la Academia Europea de Neurología que evalúan la experiencia de AJOVY® (fremanezumab) en poblaciones con migraña difícil de tratar | Business Wire Resumen: Teva ha pesentado nuevos datos en el congreso de la Academia Europea de Neurología que evalúan la experiencia de AJOVY® (fremanezumab) en poblaciones con migraña difícil de tratar | Business Wire](https://mms.businesswire.com/media/20200525005196/es/739014/23/teva_RGB_JPEG.jpg)
Resumen: Teva ha pesentado nuevos datos en el congreso de la Academia Europea de Neurología que evalúan la experiencia de AJOVY® (fremanezumab) en poblaciones con migraña difícil de tratar | Business Wire
![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Suomi Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Suomi](https://www.ypsomed.com/assets/images/a/Ajovy_Pen_CMYK_DE_ohneSchatten_low-0cf8c7a4.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Suomi
![InvisiblyMe on Twitter: "First self-injection #Ajovy (#fremanezumab) for chronic #migraines 🎉 It was only granted #NHS use by #NICE last yr & it's reserved for the most severe cases. Trying to keep InvisiblyMe on Twitter: "First self-injection #Ajovy (#fremanezumab) for chronic #migraines 🎉 It was only granted #NHS use by #NICE last yr & it's reserved for the most severe cases. Trying to keep](https://pbs.twimg.com/media/FDrrKZjX0AcIcao.jpg:large)
InvisiblyMe on Twitter: "First self-injection #Ajovy (#fremanezumab) for chronic #migraines 🎉 It was only granted #NHS use by #NICE last yr & it's reserved for the most severe cases. Trying to keep
RIC diagnostica - AJOVY, INYECCIÓN CONTRA LA MIGRAÑA Teva Pharmaceutical anunció que Ajovy 225 mg (fremanezumab) se trata de una inyección, cuyo objetivo es prevenir la migraña en adultos que tienen al
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting
![Fremanezumab, disponible ya en España para la prevención de la migraña episódica y crónica - Farmacosalud Fremanezumab, disponible ya en España para la prevención de la migraña episódica y crónica - Farmacosalud](https://farmacosalud.com/wp-content/uploads/2020/07/600-AJOVY-fremanezumab-Ajovy-TEVA.jpg)